Blood Safety

Development of New Reagents to Test for HCV Could be Beneficial to Blood Banks

Published in Hepatitis Weekly, September 4th, 2000

Blood donors in Egypt are reportedly infected with hepatitis C virus at a rate of 24%. Scientists in Egypt report that this relatively high rate may be due to cross-reactivity occurring in the assays used to test blood.

Therefore, these scientists have developed a synthetic peptide that has a very high sensitivity and specificity that could potentially be used for testing blood donors in Egypt.

Results of this study were presented at the CDC 2000 Internal Conference on Emerging Infectious Diseases, which was hosted by the US Centers for Disease Control and Prevention in Atlanta, Georgia. The report was titled "Synthetic Peptides from Putative Core...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2000-09-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry